Village-Neuf, France

Karen Kammertoens

USPTO Granted Patents = 4 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Karen Kammertoens: Innovator in Pharmaceutical Chemistry

Introduction

Karen Kammertoens is a prominent inventor based in Village-Neuf, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of four patents to her name, Kammertoens is recognized for her innovative work in the industry.

Latest Patents

Among her latest patents are the dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives. These inventions relate to compounds that are suitable for the treatment of disorders or diseases mediated by the activity of the PI3K enzymes. The compounds are defined by specific formulas and include pharmaceutically acceptable salts and solvates, showcasing her expertise in creating effective therapeutic agents.

Career Highlights

Kammertoens has built a successful career at Novartis AG, where she has been instrumental in advancing research and development in pharmaceutical innovations. Her work has not only contributed to the company's portfolio but has also had a broader impact on the medical field.

Collaborations

Throughout her career, Kammertoens has collaborated with notable colleagues, including Giorgio Caravatti and Sylvie Chamoin. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Karen Kammertoens stands out as a leading inventor in pharmaceutical chemistry, with her innovative patents paving the way for new treatments. Her contributions to the field exemplify the importance of research and collaboration in driving medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…